Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bendamustine

Known as: 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric Acid, Bendamustin 
The active ingredient in a drug that is used to treat chronic lymphocytic leukemia (CLL), to treat slow-growing B-cell non-Hodgkin lymphoma (NHL… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
  • S. Berentsen
  • British journal of haematology
  • 2018
  • Corpus ID: 13788361
Cold agglutinin disease (CAD) is an uncommon autoimmune haemolytic anaemia in which a well‐defined, clonal low‐grade… Expand
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab is the standard therapy for physically fit… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE We investigated the safety and efficacy of bendamustine and rituximab (BR) in previously untreated patients with chronic… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE The objective of this trial was to evaluate safety and efficacy of bendamustine combined with rituximab (BR) in patients… Expand
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Given the significant activity and tolerability of bendamustine, rituximab, and bortezomib in patients with relapsed indolent and… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2009
Review
2009
  • B. Cheson, M. Rummel
  • Journal of clinical oncology : official journal…
  • 2009
  • Corpus ID: 25774039
Bendamustine is a unique cytotoxic agent with structural similarities to alkylating agents and antimetabolites, but which is non… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Purpose: Bendamustine has shown clinical activity in patients with disease refractory to conventional alkylator chemotherapy. The… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Bendamustine HCl is a bifunctional mechlorethamine derivative with clinical activity in the treatment of non-Hodgkin's… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE The aim of this multicenter-study was to evaluate the progression-free survival, response rate and toxicity of the… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
Is this relevant?